Comprehensive Analysis of Conditioned Media from Ovarian Cancer Cell Lines Identifies Novel Candidate Markers of Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Comprehensive Analysis of Conditioned Media from Ovarian Cancer Cell Lines Identifies Novel Candidate Markers of Epithelial Ovarian Cancer

Published:2009-09-03 Issue:10 Volume:8 Page:4705-4713
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Gunawardana C. Geeth¹,Kuk Cynthia¹,Smith Chris R.¹,Batruch Ihor¹,Soosaipillai Antoninus¹,Diamandis Eleftherios P.¹

Affiliation:

1. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada, and Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr900411g

Reference47 articles.

1. Cancer of the Ovary

2. Status of Tumor Markers in Ovarian Cancer Screening

3. Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma

4. The role of CA125 in clinical practice

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deletion of Fbxw7 in oocytes causes follicle loss and premature ovarian insufficiency in mice;Journal of Cellular and Molecular Medicine;2024-06

2. Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer;EMBO Molecular Medicine;2024-04-24

3. Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer;PROTEOMICS – Clinical Applications;2024-01-09

4. Analysis of Cancer Cell Line Secretomes: A Complementary Source of Disease-Specific Protein Biomarkers;Methods in Molecular Biology;2023

5. Differential and divergent activity of insulin‑like growth factor binding protein 6 in platinum‑sensitive versus platinum‑resistant high‑grade serous ovarian carcinoma cell lines;Oncology Letters;2022-04-21